• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NR2B 型 N-甲基-D-天冬氨酸受体在亨廷顿病选择性神经变性中的作用

Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease.

作者信息

Li Lijun, Fan Mannie, Icton Carolyn D, Chen Nansheng, Leavitt Blair R, Hayden Michael R, Murphy Tim H, Raymond Lynn A

机构信息

Kinsmen Laboratories, Department of Psychiatry, University of British Columbia, 4N3-2255 Westbrook Mall, BC, Vancouver, Canada V6T 1Z3.

出版信息

Neurobiol Aging. 2003 Dec;24(8):1113-21. doi: 10.1016/j.neurobiolaging.2003.04.003.

DOI:10.1016/j.neurobiolaging.2003.04.003
PMID:14643383
Abstract

N-Methyl-D-aspartate receptor (NMDAR)-mediated excitotoxicity has been proposed to play a role in Huntington disease (HD), caused by expansion of a polyglutamine tract in the protein huntingtin. HD is characterized by selective neurodegeneration most severely affecting striatal medium-sized spiny projection neurons (MSNs), where expression of the NMDAR subunit NR2B is increased relative to other NR2 subunits. Here, we review our data that NR2B-type NMDAR currents are selectively potentiated by mutant huntingtin in transfected non-neuronal cells and acutely dissociated striatal MSNs from the YAC72 transgenic mouse model of HD. As well, we report increased striatal MSN NMDAR-mediated synaptic currents in corticostriatal slice recordings from YAC72 compared with wild-type mice. This effect was associated with a larger NMDAR- to AMPAR-mediated current ratio, suggesting specific potentiation of postsynaptic NMDARs. Enhanced NMDAR current likely involves increased surface receptor numbers or activity, since we observed no differences between genotypes in striatal NR2B expression. Potentiation of NR2B-containing NMDAR current in striatal MSNs expressing mutant huntingtin may help explain the exquisite vulnerability of these neurons to degeneration in HD.

摘要

N-甲基-D-天冬氨酸受体(NMDAR)介导的兴奋性毒性被认为在亨廷顿舞蹈症(HD)中起作用,HD由亨廷顿蛋白中多聚谷氨酰胺序列的扩增引起。HD的特征是选择性神经退行性变,最严重影响纹状体中型棘状投射神经元(MSN),其中NMDAR亚基NR2B的表达相对于其他NR2亚基增加。在此,我们回顾我们的数据,即NR2B型NMDAR电流在转染的非神经元细胞以及来自HD的YAC72转基因小鼠模型的急性分离的纹状体MSN中被突变型亨廷顿蛋白选择性增强。同样,我们报告与野生型小鼠相比,来自YAC72的皮质纹状体切片记录中纹状体MSN的NMDAR介导的突触电流增加。这种效应与更大的NMDAR与AMPA受体介导的电流比率相关,表明突触后NMDAR的特异性增强。增强的NMDAR电流可能涉及表面受体数量或活性的增加,因为我们在纹状体NR2B表达中未观察到基因型之间的差异。在表达突变型亨廷顿蛋白的纹状体MSN中含NR2B的NMDAR电流的增强可能有助于解释这些神经元在HD中对变性的极度易感性。

相似文献

1
Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease.NR2B 型 N-甲基-D-天冬氨酸受体在亨廷顿病选择性神经变性中的作用
Neurobiol Aging. 2003 Dec;24(8):1113-21. doi: 10.1016/j.neurobiolaging.2003.04.003.
2
Enhanced striatal NR2B-containing N-methyl-D-aspartate receptor-mediated synaptic currents in a mouse model of Huntington disease.亨廷顿病小鼠模型中纹状体含NR2B的N-甲基-D-天冬氨酸受体介导的突触电流增强
J Neurophysiol. 2004 Nov;92(5):2738-46. doi: 10.1152/jn.00308.2004. Epub 2004 Jul 7.
3
Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity.聚谷氨酰胺调节的YAC转基因亨廷顿病小鼠模型纹状体钙蛋白酶活性:对NMDA受体功能和毒性的影响
J Neurosci. 2008 Nov 26;28(48):12725-35. doi: 10.1523/JNEUROSCI.4619-08.2008.
4
Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington's disease.突触后致密蛋白95与N-甲基-D-天冬氨酸受体的相互作用影响亨廷顿舞蹈病酵母人工染色体小鼠模型中的兴奋性毒性。
J Neurosci. 2009 Sep 2;29(35):10928-38. doi: 10.1523/JNEUROSCI.2491-09.2009.
5
Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.在亨廷顿舞蹈症的YAC小鼠模型中,全长突变型亨廷顿蛋白对于纹状体神经元Ca2+信号改变和细胞凋亡是必需的。
Neurobiol Dis. 2008 Jul;31(1):80-8. doi: 10.1016/j.nbd.2008.03.010. Epub 2008 Apr 16.
6
Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease.亨廷顿舞蹈病酵母人工染色体转基因小鼠模型中N-甲基-D-天冬氨酸受体转运的改变
J Neurosci. 2007 Apr 4;27(14):3768-79. doi: 10.1523/JNEUROSCI.4356-06.2007.
7
Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load.亨廷顿舞蹈症小鼠模型中的皮质纹状体突触功能:亨廷顿蛋白重复序列长度和蛋白负荷的早期影响
J Physiol. 2007 Dec 15;585(Pt 3):817-31. doi: 10.1113/jphysiol.2007.142448. Epub 2007 Oct 18.
8
NMDA receptor function in mouse models of Huntington disease.亨廷顿病小鼠模型中的NMDA受体功能
J Neurosci Res. 2001 Nov 15;66(4):525-39. doi: 10.1002/jnr.1244.
9
Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease.在亨廷顿舞蹈症的R6/2小鼠模型中,N-甲基-D-天冬氨酸受体敏感性和镁离子阻断的改变在发育早期就会出现。
J Neurosci Res. 2005 Nov 1;82(3):377-86. doi: 10.1002/jnr.20651.
10
Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease.亨廷顿舞蹈病小鼠模型中对N-甲基-D-天冬氨酸受体介导的兴奋毒性的敏感性增加。
Neuron. 2002 Mar 14;33(6):849-60. doi: 10.1016/s0896-6273(02)00615-3.

引用本文的文献

1
NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies.神经退行性疾病中的N-甲基-D-天冬氨酸受体:机制与新兴治疗策略
Front Aging Neurosci. 2025 Jul 24;17:1604378. doi: 10.3389/fnagi.2025.1604378. eCollection 2025.
2
Thalamostriatal degeneration contributes to dystonia and cholinergic interneuron dysfunction in a mouse model of Huntington's disease.苍白球丘脑变性导致亨廷顿病小鼠模型的肌张力障碍和胆碱能中间神经元功能障碍。
Acta Neuropathol Commun. 2020 Feb 7;8(1):14. doi: 10.1186/s40478-020-0878-0.
3
Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models.
亨廷顿病的细胞自主和非细胞自主发病机制:体外和体内模型的见解。
Neurotherapeutics. 2019 Oct;16(4):957-978. doi: 10.1007/s13311-019-00782-9.
4
Calcium-Handling Defects and Neurodegenerative Disease.钙处理缺陷与神经退行性疾病。
Cold Spring Harb Perspect Biol. 2020 Jul 1;12(7):a035212. doi: 10.1101/cshperspect.a035212.
5
Cause or compensation?-Altered neuronal Ca handling in Huntington's disease.病因还是补偿机制?——亨廷顿病中神经元钙处理的改变。
CNS Neurosci Ther. 2018 Apr;24(4):301-310. doi: 10.1111/cns.12817. Epub 2018 Feb 9.
6
Inflammation alters AMPA-stimulated calcium responses in dorsal striatal D2 but not D1 spiny projection neurons.炎症改变背侧纹状体 D2 但不改变 D1 棘突投射神经元中 AMPA 刺激的钙反应。
Eur J Neurosci. 2017 Nov;46(9):2519-2533. doi: 10.1111/ejn.13711. Epub 2017 Oct 10.
7
Cognitive dysfunction in Huntington's disease: mechanisms and therapeutic strategies beyond BDNF.亨廷顿舞蹈病中的认知功能障碍:超越脑源性神经营养因子的机制与治疗策略
Brain Pathol. 2016 Nov;26(6):752-771. doi: 10.1111/bpa.12432.
8
Levodopa-Induced Dyskinesia Is Related to Indirect Pathway Medium Spiny Neuron Excitotoxicity: A Hypothesis Based on an Unexpected Finding.左旋多巴诱导的异动症与间接通路中型多棘神经元兴奋性毒性有关:基于一项意外发现的假说
Parkinsons Dis. 2016;2016:6461907. doi: 10.1155/2016/6461907. Epub 2016 Apr 6.
9
Aging of the NMDA receptor: from a mouse's point of view.NMDA受体的老化:从老鼠的视角来看
Future Neurol. 2012 Sep;7(5):627-637. doi: 10.2217/fnl.12.54.
10
The effects of NMDA subunit composition on calcium influx and spike timing-dependent plasticity in striatal medium spiny neurons.NMDA 亚基组成对纹状体中间神经元钙内流和时程依赖型可塑性的影响。
PLoS Comput Biol. 2012;8(4):e1002493. doi: 10.1371/journal.pcbi.1002493. Epub 2012 Apr 19.